Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?

Araki Daisuke; Othus Megan; Walter Roland B.; Becker Pamela S.; Sandhu Vicky; Estey Elihu H.

首页> 外文期刊>Leukemia and lymphoma >Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?

【24h】

Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?

机译：复发或难治性急性髓细胞性白血病第二次挽救疗法的结果是否取决于第一次或第二次挽救疗法的强度？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2016年第5期|共3页
作者
Araki Daisuke; Othus Megan; Walter Roland B.; Becker Pamela S.; Sandhu Vicky; Estey Elihu H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy? [J] . Araki Daisuke, Othus Megan, Walter Roland B., Leukemia and lymphoma . 2016,第5期

机译：复发或难治性急性髓细胞性白血病第二次挽救疗法的结果是否取决于第一次或第二次挽救疗法的强度？
2. Outcomes with Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine as Salvage Therapy for Relapsed/Refractory Acute Myeloid Leukemia [J] . Prajwal Boddu, Nitin Jain, Farhad Ravandi, Clinical lymphoma, myeloma & leukemia . 2017,第10期

机译：与Defitabine的结果随后是Clofarabine，Idarubicin和Cytarabine作为复发/难治性急性髓性白血病的抢救疗法
3. Outcomes with Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine as Salvage Therapy for Relapsed/Refractory Acute Myeloid Leukemia [J] . Boddu Prajwal, Jain Nitin, Ravandi Farhad, Clinical lymphoma, myeloma & leukemia . 2017,第10Suppla期

机译：与Defitabine的结果随后是Clofarabine，Idarubicin和Cytarabine作为复发/难治性急性髓性白血病的抢救疗法
4. Arsenic Salvage Is Superior to Chemotherapy and Bone Marrow Transplantation for Relapsed Acute promyelocytic Leukemia: Ten Years of Experience from Hong Kong [C] . W.Y. Au, R. Liang, A.K.W. Lie, European Haematology Association . 2002

机译：砷救生优于化疗和骨髓移植复发急性突出细胞细胞白血病：来自香港的十年经验
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Comparison of High-Dose Cytarabine Mitoxantrone and Pegaspargase (HAM-pegA) to High-Dose Cytarabine Mitoxantrone Cladribine and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia [O] . Ciera L. Patzke, Alison P. Duffy, Vu H. Duong, 2020

机译：高剂量阿糖胞苷米托蒽醌和天马酰胺酶（HAM-pegA）与高剂量阿糖胞苷米托蒽醌克拉屈滨和非格司亭（CLAG-M）作为一线挽救性细胞毒性化学疗法对复发/难治性急性髓细胞白血病的比较
7. Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia [O] . Jonas Westhus, Richard Noppeney, Christine Schmitz, 2019

机译：Etoposide联合国旗救生疗法在多重复发/难治性急性髓性白血病中是有效的

Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?

著录项

相似文献

相关主题

期刊订阅